Are you qualified to be the next CMO of the Olympic Games? Our guest, Dr. John Cantwell, Cardiologist and CMO of the 1996 summer games in Atlanta share his experiences managing the health of the athletes, their families and 1.5 million spectators as the CMO of the Atlanta Games in 1996. What were the greatest challenges? Were they prepared for the bomb? Join host Dr. Larry Kaskel to learn how Dr. Cantwell's preparation differs from the types of preparation required of the 2008 medical team heading to Beijing.
The Role of an Olympic Chief Medical Officer
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Are you qualified to be the next CMO of the Olympic Games? Our guest, Dr. John Cantwell, Cardiologist and CMO of the 1996 summer games in Atlanta share his experiences managing the health of the athletes, their families and 1.5 million spectators as the CMO of the Atlanta Games in 1996. What were the greatest challenges? Were they prepared for the bomb? Join host Dr. Larry Kaskel to learn how Dr. Cantwell's preparation differs from the types of preparation required of the 2008 medical team heading to Beijing.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
MinuteCE®
Clinical Conundrums in ARIA: 1. Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
1.25 credits
<p>Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies</p>
MinuteCE®
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
1.25 credits
<p>Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy</p>
CME/CE
Personalizing Care Within the RCC Treatment Paradigm
1.00 credits
<p>Personalizing Care Within the RCC Treatment Paradigm</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
<p>Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?